01324-6/asset/4a54a807-9d4c-43b0-9cee-525570c8c25d/main.assets/gr2_lrg.jpg)
glp-1 trial results today Efficacy and safety of a novel dual GIP and receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 New GLP-1 clinical trial data
Description
2026 Jan 29
In a person with type 2 diabetes, the liver may release excess glucose even when blood glucose levels are already elevated, compounding the hyperglycemia
[DOI] [PMC free article] [PubMed] [Google Scholar] 269.Little, T
Where do PBMs fit in
Similarly, TSMC (semiconductor giant) uses Omniverse to turn 2D CAD drawings of a new chip fab into an interactive 3D layout
Heart disease, stroke, osteoarthritis, and some cancers) Desire physician-supervised weight loss
